FDA Informs Eisai Medical Research on 'Misleading' Aricept TV Ads

ROCKVILLE, Md., Feb. 18, 2010--The FDA has posted on its website a letter regarding two television ads for the Alzheimer’s disease drug Aricept. The agency said the ads are misleading because they overstate the drug's efficiacy. 

www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM201238.pdf 

 

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM201240.pdf

Posted: February 2010


View comments

Hide
(web4)